Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopido-grel in patients with acute coronary syndromes - Storey, RF; Husted, S; Harrington, RA (J Am Coll Cardiol, 2007)